NIFTY 50

Eris Lifesciences acquires anti-diabetes drug Zomelis from Novartis for $13 million

Updated : December 04, 2019 11:20 AM IST

Eris Lifesciences acquired the trademark for anti-diabetes drug Zomelis from Novartis AG for a consideration of $13 million.
The company will start selling the drug in the Indian market from December 10 onwards.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV